Overexpression of c-FLIP has been observed in several types of malignancies including colorectal carcinoma, hepatocellular carcinoma, pancreatic carcinoma, and prostate carcinoma, and might be associated with cancer progression given the ability of c-FLIP to inhibit apoptosis [16, 28–31]. This evidence concerns the gene CFLAR and exocrine pancreatic carcinoma.